Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...

Evercore ISI analyst David Raso maintained a Hold rating on Deere (DE – Research Report) yesterday and set a price target of $455.00. The ...

QuantumScape (NYSE:QS – Get Free Report) had its price target lowered by analysts at Evercore ISI from $10.00 to $8.00 in a ...

Evercore ISI analyst Michael Lonegan maintained a Hold rating on Entergy (ETR – Research Report) yesterday and set a price target of $86.00.

Magna International (NYSE:MGA – Get Free Report) (TSE:MG) had its price target reduced by stock analysts at Evercore ISI from ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against the other AI stocks. Tiger ...

Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 ( SP500 ), ( ...

While Evercore ISI acknowledged these challenges are "addressable," the firm believes it will take time to resolve them. "We may be wrong in our fundamental attribution, but this is our best guess ...

Mark Mahaney, Evercore ISI Head of Internet Research, joins 'Closing Bell Overtime' to talk Airbnb and Roku earnings.

Evercore ISI has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to outperform from in line, citing upcoming catalysts. The investment firm said it was now including the CTX320 and CTX310 in vivo ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (LSE:0VRQ) from In-Line to Outperform. There are 577 funds or institutions reporting ...